MTHFR testing is common in direct-to-consumer (DTC) tests, but the evidence for clinical action based solely on genotype is weak. Most individuals with an MTHFR variant have normal homocysteine levels and do not require special methylated folate. The key biomarker is blood homocysteine, not the gene variant alone. The link to fatigue or other symptoms is small and based mainly on observational studies with modest effect sizes. Standard folic acid works for most people. DTC tests often overstate the significance. Self-supplementing with high-dose methylfolate is not recommended without medical guidance, as it may cause side effects. Get homocysteine and other markers checked by a doctor. Evidence grade: human-moderate. Source: PMC11399056.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-c5d6c1b20d1fa5e260ae398e